1.Eisenbarth GS. Type I diabetes mellitus. A chronic autoimmune disease. The New England journal of medicine. 1986;314(21):1360-8.
2.Bottazzo GF, Florin-Christensen A, Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet (London, England). 1974;2(7892):1279-83.
3.Gierach M, Gierach J, Junik R. Insulin resistance and thyroid disorders. Endokrynologia Polska. 2014;65(1):70-6.
4.Voulgari PV, Venetsanopoulou AI, Kalpourtzi N, Gavana M, Vantarakis A, Hadjichristodoulou C, et al. Thyroid dysfunction in Greece: Results from the national health examination survey EMENO. PloS one. 2022;17(3):e0264388.
5.Salloum M, Poole R. The challenges of managing type 1 diabetes with other autoimmune diseases. Practical Diabetes. 2022;39(5):32-5a.
6.Chan JCN, Lim L-L, Wareham NJ, Shaw JE, Orchard TJ, Zhang P, et al. The <em>Lancet</em> Commission on diabetes: using data to transform diabetes care and patient lives. The Lancet. 2020;396(10267):2019-82.
7.National Institute of Diabetes and Digestive Diseases. National Diabetes Statistics fact sheet: general information and national estimates on diabetes in the United States. 2005.
8.Bogusławska J, Godlewska M, Gajda E, Piekiełko-Witkowska A. Cellular and molecular basis of thyroid autoimmunity. European thyroid journal. 2022;11(1).
9.Glassman CR, Su L, Majri-Morrison SS, Winkelmann H, Mo F, Li P, et al. Calibration of cell-intrinsic interleukin-2 response thresholds guides design of a regulatory T cell biased agonist. eLife. 2021;10:e65777.
10.Antonelli A, Ferrari SM, Corrado A, Di Domenicantonio A, Fallahi P. Autoimmune thyroid disorders. Autoimmunity reviews. 2015;14(2):174-80.
11.Fernández-Castañer M, Molina A, López-Jiménez L, Gómez JM, Soler J. Clinical presentation and early course of type 1 diabetes in patients with and without thyroid autoimmunity. Diabetes care. 1999;22(3):377-81.
12.Kim YS, Han K, Lee JH, Kim NI, Roh JY, Seo SJ, et al. Increased Risk of Chronic Spontaneous Urticaria in Patients With Autoimmune Thyroid Diseases: A Nationwide, Population-based Study. Allergy, asthma & immunology research. 2017;9(4):373-7.
13.Pedullá M, Fierro V, Papacciuolo V, Alfano R, Ruocco E. Atopy as a risk factor for thyroid autoimmunity in children affected with atopic dermatitis. Journal of the European Academy of Dermatology and Venereology : JEADV. 2014;28(8):1057-60.
14.Kylökäs A, Kaukinen K, Huhtala H, Collin P, Mäki M, Kurppa K. Type 1 and type 2 diabetes in celiac disease: prevalence and effect on clinical and histological presentation. BMC gastroenterology. 2016;16(1):76.
15.Prazny M, Skrha J, Limanova Z, Vanickova Z, Hilgertova J, Prazna J, et al. Screening for associated autoimmunity in type 1 diabetes mellitus with respect to diabetes control. Physiological research. 2005;54(1):41-8.
16.Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999. Diabetic medicine : a journal of the British Diabetic Association. 2006;23(8):857-66.
17.Steck AK, Johnson K, Barriga KJ, Miao D, Yu L, Hutton JC, et al. Age of islet autoantibody appearance and mean levels of insulin, but not GAD or IA-2 autoantibodies, predict age of diagnosis of type 1 diabetes: diabetes autoimmunity study in the young. Diabetes care. 2011;34(6):1397-9.
18.Jongejan RMS, van Velsen EFS, Meima ME, Klein T, van den Berg SAA, Massolt ET, et al. Change in Thyroid Hormone Metabolite Concentrations Across Different Thyroid States. Thyroid : official journal of the American Thyroid Association. 2022;32(2):119-27.
19.Kadiyala R, Peter R, Okosieme OE. Thyroid dysfunction in patients with diabetes: clinical implications and screening strategies. International journal of clinical practice. 2010;64(8):1130-9.
20.Levin L, Tomer Y. The etiology of autoimmune diabetes and thyroiditis: evidence for common genetic susceptibility. Autoimmunity Reviews. 2003;2(6):377-86.
21.Liu Z, Zhang L, Qian C, Zhou Y, Yu Q, Yuan J, et al. Recurrent hypoglycemia increases hepatic gluconeogenesis without affecting glycogen metabolism or systemic lipolysis in rat. Metabolism: clinical and experimental. 2022;136:155310.
22.Roldán MB, Alonso M, Barrio R. Thyroid autoimmunity in children and adolescents with Type 1 diabetes mellitus. Diabetes, nutrition & metabolism. 1999;12(1):27-31.
23.Ghosh R, Chatterjee S, Dubey S, Pandit A, Ray BK, Benito-León J. Anti-Thyroid Peroxidase/Anti-Thyroglobulin Antibody-Related Neurologic Disorder Responsive to Steroids Presenting with Pure Acute Onset Chorea. Tremor and other hyperkinetic movements (New York, NY). 2020;10:19.
24.Cohen SB, Katsikis PD, Chu CQ, Thomssen H, Webb LM, Maini RN, et al. High level of interleukin-10 production by the activated T cell population within the rheumatoid synovial membrane. Arthritis Rheum. 1995;38(7):946-52.
25.Hansen D, Bennedbaek F, Hoier-Madsen M, Hegedus L, Jacobsen B. A prospective study of thyroid function, morphology and autoimmunity in young patients with type 1 diabetes. European journal of endocrinology. 2003;148(2):245-51.
26.Sharifi F, GHASEMI L, MOUSAVINASAB S. Thyroid function and anti-thyroid antibodies in Iranian patients with type 1 diabetes mellitus: influences of age and sex. 2008.
27.Balasa B, Davies JD, Lee J, Good A, Yeung BT, Sarvetnick N. IL-10 impacts autoimmune diabetes via a CD8+ T cell pathway circumventing the requirement for CD4+ T and B lymphocytes. Journal of immunology (Baltimore, Md : 1950). 1998;161(8):4420-7.
28.Pennline KJ, Roque-Gaffney E, Monahan M. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clinical immunology and immunopathology. 1994;71(2):169-75.
29.He JS, Xie PS, Luo DS, Sun CJ, Zhang YG, Liu FX. Role of immune dysfunction in pathogenesis of type 1 diabetes mellitus in children. Asian Pacific journal of tropical medicine. 2014;7(10):823-6.
30.Reis JS, Amaral CA, Volpe CM, Fernandes JS, Borges EA, Isoni CA, et al. Oxidative stress and interleukin-6 secretion during the progression of type 1 diabetes. Arquivos brasileiros de endocrinologia e metabologia. 2012;56(7):441-8.
31.Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. American journal of physiology Endocrinology and metabolism. 2001;280(5):E745-51.
32.Barton BE. The biological effects of interleukin 6. Medicinal research reviews. 1996;16(1):87-109.
33.Wędrychowicz A, Dziatkowiak H, Sztefko K, Wędrychowicz A. Interleukin-6 (IL-6) and IGF-IGFBP system in children and adolescents with type 1 diabetes mellitus. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association. 2004;112 8:435-9.
34.Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. Journal of Clinical Epidemiology. 2009;62(10):1006-12.
35.Pickup JC, Mattock MB, Chusney GD, Burt D. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia. 1997;40(11):1286-92.
36.Heier M, Margeirsdottir HD, Brunborg C, Hanssen KF, Dahl-Jørgensen K, Seljeflot I. Inflammation in childhood type 1 diabetes; influence of glycemic control. Atherosclerosis. 2015;238(1):33-7.
37.Talaat IM, Nasr A, Alsulaimani AA, Alghamdi H, Alswat KA, Almalki DM, et al. Association between type 1, type 2 cytokines, diabetic autoantibodies and 25-hydroxyvitamin D in children with type 1 diabetes. Journal of endocrinological investigation. 2016;39(12):1425-34.
38.Bradshaw EM, Raddassi K, Elyaman W, Orban T, Gottlieb PA, Kent SC, et al. Monocytes from patients with type 1 diabetes spontaneously secrete proinflammatory cytokines inducing Th17 cells. Journal of immunology (Baltimore, Md : 1950). 2009;183(7):4432-9.
39.Jacob CO, McDevitt HO. Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis. Nature. 1988;331(6154):356-8.
40.Pan X, Kaminga AC, Kinra S, Wen SW, Liu H, Tan X, et al. Chemokines in Type 1 Diabetes Mellitus. Frontiers in immunology. 2021;12:690082.